Management Strategies, Associated Complications, and Prognostic Determinants in Thyroid Carcinoma: An observational analysis
Background: Thyroid carcinoma is the most common endocrine malignancy, exhibiting diverse histopathological patterns and variable prognostic outcomes. Early detection and ‘ risk-adapted management are essential to optimize long-term survival. Aim: To evaluate the management strategies, associated complications, and prognostic determinants in patients with thyroid carcinoma. Methodology: A hospital-based observational analytical study was conducted in the Department of General Surgery, IGIMS, Patna, including 90 histopathologically confirmed cases of ‘ thyroid carcinoma. Data on demographics, tumor characteristics, surgical and adjuvant treatment, complications, recurrence, and survival were analyzed. Results: Most patients were middle-aged (31–50 years, 38.9%) with a slight male predominance (55.6%). Papillary carcinoma was the most common type (66.7%), and 44.4% were diagnosed at Stage I. Total thyroidectomy (61.1%) followed by thyroxine suppression therapy (77.8%) was the principal management approach. Postoperative complications were infrequent, with hypocalcemia being the most common (16.7%). Tumor size >2 cm, lymph node involvement, and aggressive histopathological variants were identified as major prognostic determinants. The overall recurrence rate was 10%, while 1-year and 3-year survival rates were 85% and 75%, respectively. Conclusion: Early-stage tumors, smaller size, absence of’ nodal involvement, and non-aggressive histology are associated with favorable outcomes. A risk-stratified treatment approach—primarily total thyroidectomy with selective lymph node dissection and appropriate adjuvant ‘ therapy—remains essential for optimizing long-term disease control.